Here are seven observations:
1. An increasing aging population, lower revision surgery rate and demand for advanced CTDR devices will boost the market.
2. Key trends driving the market include technological advancements; robust research and development activity investments; and an acquisition and merger surge.
3. The metal-on-biocompatible material segment accounts for the greatest CTDR device market share, above metal-on-metal. This is due to the material yielding a greater rotation degree and flexibility of the spine.
4. Although the hospital segment led the cervical total disc replacement device market in terms of end-user in 2014, ambulatory surgery centers are anticipated to grow at a higher compound annual growth rate through 2021. This growth in ASCs is due to patient demand for quick discharge and lower costs.
5. North America dominates the cervical total disc replacement device market because of strong reimbursement policies and a jump in the amount of cervical disc replacement procedures performed.
6. The Asia-Pacific region’s large population will drive market growth.
7. Key cervical total disc replacement device market players include Dublin, Ireland-based Medtronic; Raynham, Mass.-based DePuy Synthes; Audubon, Pa.-based Globus Medical; San Diego-based NuVasive; and Warsaw, Ind.-based Zimmer Biomet.
More articles on devices:
15 things to know about cervical artificial disc replacement
Mazor X now utilized in 5 hospitals worldwide — 4 key notes
Nemours Children’s Health System buys 3rd EOS imagine device — 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
